Semaglutide Versus Dulaglutide or Empagliflozin: Death and Cardiovascular Outcomes for Patients With Type 2 Diabetes

0:00-29:55

Dr. Centor discusses outcomes in patients with type 2 diabetes when treated with semaglutide or dulaglutide versus empagliflozin with Drs. Kevin Kip and Anum Saeed.

Publisher

Annals On Call Podcast

Link

media.acponline.org/annals/audio/a25-semaglutide-vs-dulaglutide-or-empagliflozin.mp3

Published

August 18, 2025

Duration

30 min

Format

Podcast

Category

Lifestyle · Medicine

Source

RSS feed

Host

American College of Physicians

AO

Annals On Call Podcast

@annalsoncallpodcast

#semaglutideversusdulaglutide #empagliflozin #cardiovascularoutcomes #medicine

The Nile